LENSAR, Inc. (LNSR) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Devices 行业. 公司总部位于 Orlando, FL, 美国. 现任CEO为 Nicholas T. Curtis.
LNSR 拥有 IPO日期为 2020-10-02, 140 名全职员工, 在 NASDAQ Capital Marke, 市值为 $75.6M.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
